Overview

Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The efficacy and safety of rotigotine in the treatment of patients with early stage of primary Parkinson's disease
Phase:
Phase 3
Details
Lead Sponsor:
Peking University Third Hospital
Treatments:
Rotigotine